Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine Responsiveness.

With regard to IL-2 response, CD4+ memory T cells showed a trend toward decreased percentages of pSTAT5 in response to IL-2 ( Figure 3 F and Figure S1, SDC, http://links.lww.com/TXD/A26 ).

also in 53,322 other papers